Skip navigation

Wednesday, December 13, 2017

7:30

Main Conference Registration

8:30

Chairman’s Welcome and Opening Remarks

Jonathan Schmid-Burgk, PhD
Zhang Lab Postdoctoral Fellow
Broad Institute of MIT and Harvard

8:45

Mitigation of CRISPR Off-Target Effects Using Novel HiFi Cas9 Mutants

Mark A. Behlke, MD, PhD
Chief Scientific Officer
Integrated DNA Technologies, Inc.

9:30

Advance Research Using CRISPR and NGS

Michael G. Smith, PhD
Senior Sequencing Specialist
Illumina

10:15

Networking and Refreshment Break

10:45

Software Solutions for High — Throughput Genome Editing

Jonathan Schmid-Burgk, PhD
Zhang Lab Postdoctoral Fellow
Broad Institute of MIT and Harvard

11:30

Transform Genome-Editing Through A.I. Implementation

Niven Narain
Co-Founder, President & CEO
Berg Health

12:15

LUNCH AND LEARN | Fuel the Future

Meet your peers and exchange solutions across subject areas during a roundtable discussion on pressing issues related to CRISPR and explore future applications of the technology.

1:30

Use Novel Target Identification and Validation Techniques to Optimize Drug Discovery

Martin Akerman
CEO and co-founder
Envisagenics, Inc.

2:15

Building a Culture of Innovation

Amrit Chaudhuri
CEO & Founder
Mass Innovation Labs

3:00

Networking and Refreshment Break

3:30

Scaling Up the Promise of Genome-Editing

Lance Weed
Vice President, Operations
uniQure

4:15

Genome-Editing with CRISPR/Cas9 in Adoptive T-Cell Immunotherapies for Cancer

Marco Ruella, MD
Clinical Instructor, Associate Director,
Dr. June’s Laboratory, Center for Cellular Immunotherapies
University of Pennsylvania

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following close of forum

Want more agenda details? Download the brochure.

Wednesday, December 13, 2017

7:30

Main Conference Registration

8:30

Chairman’s Welcome and Opening Remarks

Jonathan Schmid-Burgk, PhD
Zhang Lab Postdoctoral Fellow
Broad Institute of MIT and Harvard

8:45

Mitigation of CRISPR Off-Target Effects Using Novel HiFi Cas9 Mutants

Mark A. Behlke, MD, PhD
Chief Scientific Officer
Integrated DNA Technologies, Inc.

9:30

Advance Research Using CRISPR and NGS

Michael G. Smith, PhD
Senior Sequencing Specialist
Illumina

10:15

Networking and Refreshment Break

10:45

Software Solutions for High — Throughput Genome Editing

Jonathan Schmid-Burgk, PhD
Zhang Lab Postdoctoral Fellow
Broad Institute of MIT and Harvard

11:30

Transform Genome-Editing Through A.I. Implementation

Niven Narain
Co-Founder, President & CEO
Berg Health

12:15

LUNCH AND LEARN | Fuel the Future

Meet your peers and exchange solutions across subject areas during a roundtable discussion on pressing issues related to CRISPR and explore future applications of the technology.

1:30

Use Novel Target Identification and Validation Techniques to Optimize Drug Discovery

Martin Akerman
CEO and co-founder
Envisagenics, Inc.

2:15

Building a Culture of Innovation

Amrit Chaudhuri
CEO & Founder
Mass Innovation Labs

3:00

Networking and Refreshment Break

3:30

Scaling Up the Promise of Genome-Editing

Lance Weed
Vice President, Operations
uniQure

4:15

Genome-Editing with CRISPR/Cas9 in Adoptive T-Cell Immunotherapies for Cancer

Marco Ruella, MD
Clinical Instructor, Associate Director,
Dr. June’s Laboratory, Center for Cellular Immunotherapies
University of Pennsylvania

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following close of forum